An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)

NCT07344376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

MPS II
Hunter Syndrome (MPS II)
Hunter Syndrome
Hunterase
GC1111

Interventions

DRUG: Hunterase

Sponsor

GC Biopharma Corp

Collaborators

[object Object]